• ES
  • FR
  • Punto de Mira

Vaccine

  • A study with the Quimi-Vio vaccine began in Cuban province

  • Abdala vaccine authorized in children under 11 years of age

  • Abdala vaccine dossier is expected to be submitted to WHO in March

  • Almost three million doses of Cuban vaccine candidates administered

  • Anti-Flu vaccination campaign underway in Holguín

  • Argentina and Mexico Covid-19 vaccine for Latin America

  • Article on Cuba's vaccine against hepatitis B has great impact

  • Belarus, First European Country to Use a Cuban COVID-19 Vaccine

  • British magazine reviews Cuban Covid-19 vaccine

  • China ratifies will to combat fraud in vaccines against Covid-19

  • China to transfer Covid-19 vaccine technologies to other countries

  • Clinical trials of Cuba’s Mambisa vaccine candidate are advancing

  • Clinical trials on Russian Covid-19 vaccine confirm its safety

  • Covid-19 vaccine produced by Cuba and Iran report no complications

  • Cuba a commencé la production industrielle de ses candidats vaccins

  • Cuba advances in presenting anti-Covid-19 vaccines to WHO

  • Cuba and China present first patent for their Pan-Corona vaccine

  • Cuba confirms 92.28% efficacy of Abdala vaccine

  • Cuba confirms registration of vaccine against lung cancer in Belarus

  • Cuba continues clinical trials of vaccine against Covid-19

Page 1 of 4

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • End
Back to top

© 2023 Periódico ¡ahora!